Health Experts Say Expanding Vaccine Access Requires More Than Patent Waivers
Health Experts Say Expanding Vaccine Access Requires More Than Patent Waivers D.C. Health Nurse Manager Ashley Hennigan fills a syringe with a dose of the Johnson & Johnson coronavirus vaccine during a walk-up clinic at the John F. Kennedy Center for the Performing Arts' outdoor Reach area on May 6, 2021 in Washington, D.C. Chip Somodevilla / Getty Images Biolyse Pharma Corp., which makes injectable cancer drugs, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit. Watching the covid death toll climb, the company decided its new production ...